The mutagenic activity of APOBEC3A (A3A) and APOBEC3B (A3B) has recently been demonstrated to introduce somatic mutations in genomic DNA (12, 13), and those two enzymes are now recognized as endogenous causal agents responsible for the accumulation of CG to TA transitions in cancer genomes (14). The gene discussed is APOBEC3A; the disease is cancer.